Testo Blend 350

Dragon Pharma Testo Blend 350 — Triple Ester Testosterone 350mg/mL

Dragon Pharma Testo Blend 350 delivers 350 mg of combined testosterone esters per milliliter in a single oil-based solution. This sophisticated formulation unites Propionate, Enanthate, and Cypionate into one high-potency injection.

Independent laboratory analysis confirmed an actual concentration of 378.24 mg/mL, exceeding the labeled claim. This overfill demonstrates exceptional manufacturing precision and delivers superior value per vial.

Overview

This multi-ester suspension combines three distinct testosterone variants. Propionate provides rapid onset, Enanthate delivers sustained mid-duration release, and Cypionate ensures extended coverage.

The result is a comprehensive hormonal profile that eliminates the peaks and troughs of single-ester protocols. Users experience immediate anabolic activity within 24–48 hours while building toward stable, elevated plasma concentrations.

The 350 mg/mL concentration reduces total injection volume. A 700 mg weekly requirement demands only 2 mL of oil, minimizing site trauma and administration frequency compared to standard 250 mg/mL formulations.

Dragon Pharma manufactures under pharmaceutical-grade protocols. The verified 378.24 mg/mL potency reflects rigorous quality control and batch consistency.

Benefits

• Immediate Anabolic Activation: The Propionate fraction produces noticeable strength, aggression, and muscular fullness within 24–48 hours of the first injection.
• Sustained Hormonal Coverage: Enanthate and Cypionate esters build stable plasma levels that persist for 1–2 weeks, eliminating gaps in anabolic support.
• Accelerated Hypertrophy: The combined ester load creates a powerfully anabolic environment, dramatically increasing protein synthesis and nitrogen retention across all muscle groups.
• Enhanced Recovery Capacity: Sustained testosterone elevation shortens inter-session repair time, supporting increased training density and volume.
• Injection Efficiency: The high concentration reduces both oil volume and needle frequency, improving protocol compliance and reducing localized tissue irritation.

Main Features

• High-concentration 350 mg/mL oil-based injectable
• Triple-ester matrix: Propionate, Enanthate, and Cypionate
• Rapid onset coupled with extended duration
• Reduced injection volume per weekly dose
• Compatible with bulking, cutting, and recomposition stacks
• Independent laboratory verification exceeding labeled potency

Ingredients

Each milliliter contains 350 mg of total testosterone in a blended ester matrix. The composition includes Testosterone Propionate, Testosterone Enanthate, and Testosterone Cypionate.

The formulation utilizes pharmaceutical-grade carrier oils, benzyl alcohol as an antimicrobial preservative, and co-solvents to ensure stable suspension and optimal pharmacokinetics.

All raw materials undergo independent verification for identity, potency, and sterility prior to compounding.

How to Use

Administer via deep intramuscular injection into large muscle groups. Rotate between the gluteal muscles, vastus lateralis, and deltoids to prevent localized tissue fibrosis.

Warm the vial gently to body temperature before drawing to reduce viscosity. Aspirate prior to plunging to confirm extravascular placement.

Maintain strict aseptic technique. Cleanse the rubber septum with isopropyl alcohol before each access. Utilize sterile needles for every administration and never share injection equipment.

Store unopened vials in a temperature-stable environment between 15–30°C (59–86°F), shielded from direct light. Do not freeze.

Dosage

Intermediate and advanced users typically administer 350–700 mg weekly. Split this into two injections, for example 1 mL on Monday and Thursday, to account for the Propionate ester.

Elite performance protocols may reach 700–1050 mg weekly. At these doses, divide into three administrations on Monday, Wednesday, and Friday to maintain more stable blood levels.

The high concentration and Propionate content can increase post-injection discomfort. Warming the oil, using a 1–1.5 inch needle, and thorough site rotation minimize this effect.

Side Effects

The substantial testosterone load drives significant aromatization. Water retention, elevated blood pressure, and gynecomastia can develop rapidly without proactive estrogen management.

Aromatase inhibitor use is essential from the outset. The Propionate fraction causes early estrogenic activity, requiring immediate ancillary support rather than delayed intervention.

Androgenic manifestations including acne, increased sebum production, and accelerated scalp hair thinning in genetically predisposed individuals are common at higher doses.

Exogenous testosterone completely suppresses hypothalamic-pituitary-gonadal axis function. A comprehensive Post-Cycle Therapy protocol using Clomiphene and Tamoxifen is mandatory.

Wait approximately 2 weeks after the final injection before initiating PCT. This allows the longer Enanthate and Cypionate esters to clear systemic circulation.

Lipid profiles may shift unfavorably, with HDL suppression and LDL elevation. Regular cardiovascular exercise and a heart-healthy diet are crucial protective measures.

Safety Information

This product is intended exclusively for research purposes and use by qualified adults under appropriate supervision. It is not suitable for minors, women, or individuals with pre-existing hepatic, cardiovascular, or prostate conditions.

Regular blood work monitoring total testosterone, estradiol, liver enzymes, and lipids is essential throughout the cycle. Adjust ancillary dosing based on objective laboratory values.

Maintain a heart-healthy diet rich in omega-3 fatty acids and low in saturated fats. Regular cardiovascular exercise supports vascular health and lipid management.

Discontinue immediately and seek medical evaluation if severe chest pain, shortness of breath, jaundice, or profound mood disturbances develop.